• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动态心电图在嗜睡障碍中的诊断价值。

Diagnostic value of actigraphy in hypersomnolence disorders.

机构信息

Danish Centre for Sleep Medicine, Copenhagen University Hospital- Rigshospitalet-Glostrup, Copenhagen, Denmark.

Copenhagen University, Panum Institute, Denmark; Molecular Sleep Laboratory, Department of Clinical Biochemistry, Copenhagen University Hospital, Copenhagen, Denmark.

出版信息

Sleep Med. 2021 Sep;85:1-7. doi: 10.1016/j.sleep.2021.06.033. Epub 2021 Jun 29.

DOI:10.1016/j.sleep.2021.06.033
PMID:34265481
Abstract

OBJECTIVE

Differentiating between the central hypersomnias presents a challenge to the diagnosis of patients with hypersomnolence. Actitigraphy may support efforts to distinguish them. We aimed to evaluate: 1) the ability of actigraphy to quantify sleep continuity measures in comparison with polysomnography in patients with hypersomnolence; 2) whether actigraphy can distinguish patients with hypersomnolence with normal hypocretin-1 in cerebrospinal fluid from patients with narcolepsy type 1 and from sleep-healthy controls; and 3) the distinct activity profiles and circadian rhythms of patients with narcolepsy type 1, patients with hypersomnolence with normal hypocretin-1 in cerebrospinal fluid, and sleep-healthy controls.

METHOD

Polysomnography, multiple sleep latency tests and actigraphy were conducted in 14 patients with narcolepsy type 1, 29 patients with hypersomnolence with normal hypocretin-1 in cerebrospinal fluid and 15 sleep-healthy controls.

RESULTS

Actigraphy quantified several sleep continuity measures consistently with polysomnography in all the patients. Actigraphy distinguished patients with hypersomnolence with normal hypocretin-1 in cerebrospinal fluid from patients with narcolepsy type 1 and sleep-healthy controls. Patients with narcolepsy type 1 had poor sleep quality and altered circadian rest-activity rhythm compared with controls.

CONCLUSION

Actigraphy is an adequate tool for establishing the amount of night sleep and supports the differential diagnosis of patients with hypersomnolence.

摘要

目的

区分中枢性嗜睡症具有挑战性,这对嗜睡症患者的诊断提出了要求。活动记录仪可能有助于区分它们。我们旨在评估:1)与多导睡眠图相比,活动记录仪在评估嗜睡症患者的睡眠连续性测量方面的能力;2)活动记录仪是否可以区分脑脊液中正常食欲素-1的嗜睡症患者与 1 型发作性睡病患者和睡眠健康对照者;3)1 型发作性睡病患者、脑脊液中正常食欲素-1的嗜睡症患者和睡眠健康对照者的不同活动模式和昼夜节律。

方法

对 14 例 1 型发作性睡病患者、29 例脑脊液中正常食欲素-1的嗜睡症患者和 15 例睡眠健康对照者进行了多导睡眠图、多次睡眠潜伏期试验和活动记录仪检查。

结果

在所有患者中,活动记录仪都能一致地定量评估几个睡眠连续性测量指标,与多导睡眠图一致。活动记录仪能将脑脊液中正常食欲素-1的嗜睡症患者与 1 型发作性睡病患者和睡眠健康对照者区分开来。与对照组相比,1 型发作性睡病患者的睡眠质量较差,昼夜休息-活动节律改变。

结论

活动记录仪是评估夜间睡眠时间的有效工具,并支持嗜睡症患者的鉴别诊断。

相似文献

1
Diagnostic value of actigraphy in hypersomnolence disorders.动态心电图在嗜睡障碍中的诊断价值。
Sleep Med. 2021 Sep;85:1-7. doi: 10.1016/j.sleep.2021.06.033. Epub 2021 Jun 29.
2
Repeated polysomnography and multiple sleep latency test in narcolepsy type 1 and other hypersomnolence disorders.重复多导睡眠图和多次睡眠潜伏期试验在 1 型发作性睡病及其他睡眠过度障碍中的应用。
Sleep Med. 2023 Oct;110:91-98. doi: 10.1016/j.sleep.2023.07.029. Epub 2023 Jul 29.
3
A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness.一项针对163名原因不明的日间过度嗜睡韩国患者,关于人类白细胞抗原(HLA)分型、脑脊液下丘脑分泌素-1测量及多次睡眠潜伏期试验(MSLT)在发作性睡病诊断中的诊断效用的研究。
Sleep. 2006 Nov;29(11):1429-38. doi: 10.1093/sleep/29.11.1429.
4
The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.脑脊液下丘脑分泌素测量在发作性睡病及其他发作性睡病的诊断中的作用。
Arch Neurol. 2002 Oct;59(10):1553-62. doi: 10.1001/archneur.59.10.1553.
5
Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency.用于识别发作性睡病/下丘脑分泌素缺乏症患者的夜间快速眼动睡眠潜伏期。
JAMA Neurol. 2013 Jul;70(7):891-902. doi: 10.1001/jamaneurol.2013.1589.
6
Rapid eye movement sleep duration during the multiple sleep latency test to diagnose hypocretin-deficient narcolepsy.多导睡眠潜伏期试验中快速眼动睡眠持续时间诊断下丘脑分泌素缺乏性嗜睡症。
Sleep. 2023 Jan 11;46(1). doi: 10.1093/sleep/zsac247.
7
The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).发作性睡病临界状态:一种多模式诊断方法,包括脑脊液中食欲素-1(食欲素A)水平
Sleep Med. 2003 Jan;4(1):7-12. doi: 10.1016/s1389-9457(02)00191-0.
8
Hypocretin-1 Levels Associate with Fragmented Sleep in Patients with Narcolepsy Type 1.1型发作性睡病患者的下丘脑分泌素-1水平与睡眠片段化相关。
Sleep. 2016 May 1;39(5):1047-50. doi: 10.5665/sleep.5750.
9
The Perception and Attention Functions test battery as a measure of neurocognitive impairment in patients with suspected central disorders of hypersomnolence.知觉和注意功能测试组合作为疑似中枢性睡眠增多症患者神经认知障碍的测量指标。
J Sleep Res. 2018 Apr;27(2):273-280. doi: 10.1111/jsr.12587. Epub 2017 Aug 2.
10
Hypersomnolence and narcolepsy; a pragmatic diagnostic neurophysiological approach.嗜睡症与发作性睡病;一种实用的诊断性神经生理学方法。
Acta Neurol Belg. 2002 Mar;102(1):11-8.

引用本文的文献

1
Present and Future of Central Disorders of Hypersomnolence.发作性睡病中枢性障碍的现状与未来。
J Sleep Res. 2025 Oct;34(5):e70118. doi: 10.1111/jsr.70118. Epub 2025 Jun 18.
2
Actigraphy against 32-hour polysomnography in patients with suspected idiopathic hypersomnia.针对疑似特发性发作性睡病患者的32小时多导睡眠图进行活动监测。
J Sleep Res. 2025 Feb 20:e70007. doi: 10.1111/jsr.70007.
3
Comparison of subjectively and objectively measured sleep-wake patterns among patients with primary brain tumors.原发性脑肿瘤患者主观和客观测量的睡眠-觉醒模式比较。
Neurooncol Pract. 2024 Jul 16;11(6):779-789. doi: 10.1093/nop/npae062. eCollection 2024 Dec.
4
Lending a helping hand: the complementary role of actigraphy in the assessment of central disorders of hypersomnolence.伸出援手:活动记录仪在评估中枢性过度嗜睡障碍中的辅助作用。
Sleep. 2024 Dec 11;47(12). doi: 10.1093/sleep/zsae228.
5
Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know.当前对嗜睡症 1 及其共病的认识:临床医生需要了解的知识。
Adv Ther. 2022 Jan;39(1):221-243. doi: 10.1007/s12325-021-01992-4. Epub 2021 Dec 11.